About Us
About Evonik Industries
Evonik Industries is a global market leader in specialty chemicals, offering a broad portfolio of products & services to meet the drug delivery challenges of the pharmaceutical market. Pharma Polymers, a business line within the Chemicals Business Area of Evonik Industries, has been supplying methacrylate polymers to the pharmaceutical and fine chemicals industry over the last 50 years.
Market Strength by means of Strategic Partnership
Pharma Polymers offers the complete line of EUDRAGIT® products and related services along the value chain of our customers. For over 50 years we have proven our reliability as a quality partner to the pharmaceutical industry. Our state of the art services cover various stages of the development processes, including
- advanced technical support
- formulation development
- proof of concept
- GMP services.
Our customers see us as a strategic partner for their developments of solid oral dosage forms with a targeted drug release profile. By using our value adding business model our customers get:
- increased efficiency in their R&D and manufacturing processes
- new drug delivery technologies
- reduction of the time to market for their developments
- professional management of their product's life cycle

EUDRAGIT®
A trademark of Pharma Polymers, offers the complete range of polymers for controlled release drug formulations. EUDRAGIT® products are approved by the most important health authorities worldwide and are manufactured under GMP guidelines.
Drug Delivery Technologies
Based on experience in EUDRAGIT® polymer design and formulation know-how for pharmaceutical applications, Pharma Polymers has developed intellectual property on advanced oral drug delivery technologies.
Technical Customer Service
Evonik Röhm's Pharma Polymers' laboratories are very well equipped to the latest standards in coating technology. Our technical staff offers their expertise in formulations of dosage forms and processing technologies. The biocatalysis group assists you in development of immobilization processes and provides scale-up support. Pharma Polymers is represented worldwide either by our own subsidiaries or through our distributors. Our customers are ensured an easy and rapid access to competent and efficient technical service.
Newsletter: Pharma Polymers News #15/01, Issue 2008
Newsletter: Pharma Polymers News #15/02, Issue 2008
Newsletter: Pharma Polymers News #15/03, Issue 2008
Newsletter: Pharma Polymers News #16/01, Issue 2009
Newsletter: Pharma Polymers News #16/02, Issue 2009
Newsletter: Pharma Polymers News #16/03, Issue 2009
Evonik Röhm GmbH
Kirschenallee
Darmstadt, 64293
GERMANY
Phone: +49 6151 18 3567
Fax: +49 6151 18 3520
Contact: Jonas Johé
- EUDRAGIT® - Acrylic Drug Delivery Excipients
- 2009 Workshops Pharma Polymers
- Sustained-Release Formulations
- Protective Coatings
- Melt Extrusion
- EUDRACOL® - Drug Delivery Technology
- EUDRAPULSE® - Drug Delivery Technology
- Regulatory & Toxicology
- Enteric Coatings
- GMP Services
- Sustained Release Matrix Formulation With EUDRAGIT® NM 30 D For Soluble Drugs
- Release Modifying Potential Of EUDRAGIT® RS, RL And EUDRAGIT® NE 30 D In Multi-Particulate Systems
- Utilization Of A Novel Rotor-Granulator Powder Layering Technique To Taste Mask Acetaminophen Pellets With EUDRAGIT® E PO
- Comparison Of Moisture Protective Film Coatings On Hydrochlorothiazide Tablets
- Detection Of Curing Via NIR Shown For EUDRAGIT® RL/RS 30 D
- Effect Of Curing And Storage Conditions On Drug Release From Multi-Particulates Coated With EUDRAGIT® L 100
- Correlation Of In Vitro And In Vivo Release Of EUDRAGIT® NE 30 D Coated Venlafaxine Pellets
- Taste Masked Ondansetron Orally Disintegrating Formulations With EUDRAGIT® Polymers
- Melt Extruded Modified Release Micropellets Using Polymethacrylates
- Effect Of Different Post Coating Drying Conditions And Low Storage Temperatures On Drug Release From EUDRAGIT® L 30 D-55 Coated Multi-Particulates
- Controlled Release Formulation Of Tamsulosin HCl Using EUDRAMODE® Technology
- Organoleptically Appealing Immediate Release EUDRAGIT® Coatings
- Melt Extrusion Processes With EUDRAGIT® Polymers For Heat-Sensitive Substances Like Proteins
- Accurate GI Targeting With EUDRAGIT® FS 30 D/L 30 D-55 Mixtures
- Stoichometry Of Complexes Formed Between EUDRAGIT® E PO And EUDRAGIT® L 100-55
- Improved Curing Of EUDRAGIT® RL/RS 30 D Film Coatings By Controlled In-Process Curing In The Fluid Bed
- EUDRAGIT® Coated Sustained Release Venlafaxine Multiparticulate Formulations
- Effect Of Different Storage Conditions On Drug Release Multi-Particulates Coated With EUDRAGIT® FS 30 D
- Controlled Release Of Tamsulosin Hydrochloride Using EUDRAGIT® Polymers
- Strategies To Accelerate Drug Release At Lower pH-Values From Dosage Forms Coated With EUDRAGIT® L 30 D-55


